Pakistan Economy Update
Ard, Commenda, Sales
Transcription
- Pakistan Economy Research Entity Notification Number: REP‐005 CPI and HASCOL earnings preview Economy: Aug’16 CPI expected at 3.9%YoY Select Economic Indicators CPI Inflation Jul‐16 YoY CAD 1MFY17 USD(0.59bn) Trade Balance 1MFY17 USD(1.6bn) Remittances 1MFY17 USD1.3bn Reserves 19‐Aug‐16 USD23.08bn 6 Month KIBOR 29‐Aug‐16 6.0% 10 Year PKRV 29‐Aug‐16 6.0% Policy Rate Tuesday August 30, 2016 4.1% 5.75% Source: SBP, BMA Research During the outgoing month of Aug’16, we expect inflation to clock in at 3.9%YoY compared to 4.1%YoY in Jul’16 and average 3.7%YoY in 7MCY16. On MoM basis, CPI is expected to post a nominal uptick of 0.1%MoM compared to a change of +1.3%MoM in Jul’16 and +0.2%MoM in Aug’15. The muted trend in CPI in Aug’16 can be attributed to a downtick of 0.3%MoM in food basket (weightage: 34.8%) owing to decline in fruits and vegetables prices. At the same time, unchanged petrol and diesel prices will likely keep the change in transport basket muted. To note, average WoW change in SPI till Aug25’16 stood at –0.2% compared to average +0.4% in the preceding month. Cumulatively, average CPI in 8MCY16 is expected to clock in at 3.7%YoY compared to 2.7%YoY last year showing clear signs of evaporation of favorable base impact. We foresee 2HCY16 CPI to remain in the vicinity of 4.3%‐4.4% where the uptick in CPI will be more profound in 4QCY16 (expected average CPI: 4.5%‐4.7%). We expect real interest rate to slip below 1.0% by Dec’16 where we foresee CPI to increase to ~5.0% which will likely lead to a reversal in interest rate easing cycle. Conclusion of result season and absence of any major trigger may likely keep market range bound in near term. In FY17, magnitude of FIPI flows and direction of oil prices will remain critical to the market sentiment. HASCOL: 1HCY16 earnings expected at PKR5.8/sh, up 36%YoY HASCOL ‐ UNDERWEIGHT Target Price: PKR 207 Current Price: PKR 226 HASCOL Performance Absolute % Relative to KSE % 1M 3M 12M ‐3% 7% 6% ‐4% ‐2% ‐23% Source: PSX, BMA Research The board meeting of Hascol Petroleum Limited (HASCOL) is scheduled today to declare its 1HCY16 results. We expect the company to post NPAT of PKR703mn (EPS: PKR5.8) in 1HCY16 compared to PKR516mn (EPS: PKR4.3) in 1HCY15, depicting a growth of 36%YoY. The expected growth in earnings will likely be driven by a remarkable 2.2xYoY and 78%YoY increase in volumetric sales of MOGAS and HSD respectively. Consequently, market share of HASCOL in MOGAS and HSD registered a growth of ~3pps and ~4pps to ~8% and ~9% in 1HCY16, respectively. On the flip side, an expected i) increase of 29%YoY in finance cost and ii) ~43%YoY decline in FO margins will contain the upside in earnings during 1HCY16. In 2QCY16 alone, we expect earnings to clock in at PKR501mn (EPS: PKR4.1), up 2.1xYoY, on account of i) 74%YoY uptick in sales volume of major products and ii) reduced burden of exchange losses. With an outperformance of 28% against KSE100 in last three months, we believe the stock has priced in the positives of growing volumetric sales and other ventures. At a TP of PKR207/sh, we maintain our ‘UNDERWEIGHT’ stance on the stock. Financial Summary 1HCY16F 1HCY15 S 2QCY16F 2QCY15 S Sales 44,976 36,427 23% 24,624 17,057 44% GP 2,050 1,393 47% 1,288 776 66% Opting Exp Muhammad Affan Ismail, CFA muhammad.affan@bmacapital.com +92 111 262 111 Ext: 2058 1,005 617 63% 526 389 35% PBT 944 688 37% 708 369 92% PAT 703 516 36% 501 242 107% EPS 5.8 4.3 36% 4.1 2.0 107% Source: Company Accounts, BMA Research www.jamapunji.pk BMA Capital Management Ltd. 801 Unitower, I.I.Chundrigar Road, Karachi, 74000, Pakistan For further queries, please contact: bmaresearch@bmacapital.com or call UAN: 111‐262‐111 1
- Disclaiimer This reseaarch report is forr information purrposes only and d does not constitu ute nor is it inten nded as an offer or solicitation fo or the purchase o or sale of securities or other financial instruments. Neitther the informattion contained in n this research report nor any futu ure information m made available w with the subject m matter contained herein will form the b basis of any contract. Information n and opinions co ontained herein h have been compiled or arrived at by BMA Capital M Management Lim mited from publiccly available informatio on and sources that BMA Capital Management Lim mited believed to o be reliable. Wh hilst every care has been taken in n preparing this research report, n no research analyst, director, officer, eemployee, agent or adviser of anyy member of BM MA Capital Managgement Limited ggives or makes an ny representation, warranty or undertaking, whether eexpress or implied, and accepts no o responsibility o or liability as to th he reliability, accuracy or completteness of the info ormation set out in this research report. Any responsibility or liability fo or any information contained hereein is expressly disclaimed. All info ormation contained herein is subjeect to change at aany time withoutt notice. No member o of BMA Capital M Management Limited has an obligaation to update, m modify or amend d this research report or to otherw wise notify a read der thereof in thee event that any matteer stated herein, or any opinion, projection, foreccast or estimate set forth herein,, changes or subssequently becom mes inaccurate, o or if research on the subject company is withdrawn. Furthermore, past performance is n not indicative of ffuture results. nvestors should make m their own investment The investments and strattegies discussed herein may not be suitable for aall investors or any particular class of investor. In decisions using their own independent advvisors as they beelieve necessary and based upon their specific fin nancial situationss and investmentt objectives when n investing. Investors should consult th heir independentt advisors if theyy have any doubts as to the appliccability to their b business or investtment objectivess of the informatiion and the strategiess discussed hereiin. This research h report is beingg furnished to ceertain persons ass permitted by applicable a law, aand accordingly may not be reproduced or circulated d to any other person without thee prior written co onsent of a memb ber of BMA Capittal Management Limited. This ressearch report may not be relied upon by any retail custtomers or person to whom this research report may not be pro ovided by law. Unauthorized U usee or disclosure of this research report r is strictly prohibited. Members of BMA Capitall Management and/or a their resp pective principalss, directors, officcers and employyees may own, h have positions orr effect transactions in the securities or financial instrruments referred d herein or in thee investments of any issuers discu ussed herein, maay engage in secu urities transaction ns in a manner in nconsistent with the research contain ned in this research report and with w respect to securities s or financial instrumentts covered by thiis research report, may sell to or o buy from customerss on a principal b basis and may serrve or act as direector, placement agent, advisor or lender, or makee a market in, or may have been a manager or a cco‐manager of the mo ost recent public offering in respeect of any investm ments or issuers of such securitie es or financial instruments referen nced in this reseaarch report or may perform any otherr investment ban nking or other services for, or solicit investment b banking or other business from aany company mentioned in this research report. IInvesting in Pakistan involves a high deegree of risk and many persons, physical and legal,, may be restricte ed from dealing in the securities m market of Pakistan. Investors shou uld perform their own due diligence beefore investing. N No part of the compensation of th he authors of thiss research reportt was, is or will bee directly or indirrectly related to tthe specific recommendations or views contained in the research reporrt. By accepting th his research repo ort, you agree to b be bound by the foregoing limitattions. BMA Capiital Managementt Limited and / orr any of its affiliates, which operaate outside Pakisttan, do and seek to do business w with the companyy(s) covered in th his research documentt. Investors should consider this rresearch report aas only a single faactor in making ttheir investment decision. BMA R Research Policy p prohibits research h personnel from discllosing a recommeendation, investm ment rating, or in nvestment thesis for review by an issuer/companyy prior to the pub blication of a rese earch report containing such rating, reccommendation or investment thesis. Stock R Rating Investors should carefully read the definittions of all ratingg used within every research rep ports. In addition n, research reporrts carry an analyyst’s independen nt view and investors should ensure caareful reading off the entire reseaarch reports and not infer its contents from the raating ascribed byy the analyst. Rattings should not be used or relied upo on as investmentt advice. An inveestor’s decision to buy, hold or seell a stock should d depend on said individual’s cirrcumstances and other considerations. BMA Capital Lim mited uses a threee tier rating systtem: i) Overweigh ht, ii) Market‐weeight and iii) Unde erweight (new raating system effective Feb 29’16) with our rating b being based on total sttock returns versus BMA’s index ttarget return for tthe year. A table presenting BMA’’s rating definitio ons is given below w: Ratingg definitions Overweight Total stock return > expected d market return + + 2% Markett‐weight Expected maarket return ± 2% % Underw weight Total stock return < expected d market return ‐ 2% *Total sttock return = cap pital gain + dividend yield Old ratingg system (discardeed effective Feb 2 29’16) Buy >20% upside potential Acccumulate >=5% to <=20% upsid de potential Ho old <5% to >5% potential Reduce <=‐5% % to >=‐20% down nside potential Selll <‐20% % downside poten ntial Valuattion Method dology To arrive aat our period end d target prices, BM MA Capital uses d different valuatio on methodologiess including • Discoun nted cash flow (DCF, DDM) • Relativee Valuation (P/E, P/B, P/S etc.) • Equity & & Asset return baased methodologgies (EVA, Residuaal Income etc.)
Create FREE account or Login to add your comment